{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:53:39Z","timestamp":1794110019565,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","arthroplastytoday.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arthroplasty Today"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.artd.2024.101505","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T15:13:29Z","timestamp":1728659609000},"page":"101505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Dalbavancin Use in Bone and Joint Infections"],"prefix":"10.1016","volume":"30","author":[{"given":"Liam P.","family":"Alderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivani","family":"Sanikommu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Mears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Lowry","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Stronach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0950-5227","authenticated-orcid":false,"given":"Jeffrey B.","family":"Stambough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci","family":"Motes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan K.","family":"Dare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.artd.2024.101505_bib1","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/678600","article-title":"Deep infection after total hip replacement: a method for national incidence surveillance","volume":"35","author":"Lindgren","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.artd.2024.101505_bib2","first-page":"3","article-title":"Similar periprosthetic joint infection rates after and before a national infection control program: a study of 45,438 primary total knee arthroplasties","volume":"93","author":"Thompson","year":"2022","journal-title":"Acta Orthop"},{"key":"10.1016\/j.artd.2024.101505_bib3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/17434440.2019.1696673","article-title":"Risk factors, diagnosis and management of prosthetic joint infection after total hip arthroplasty","volume":"16","author":"Ahmed","year":"2019","journal-title":"Expert Rev Med Dev"},{"key":"10.1016\/j.artd.2024.101505_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.surge.2015.12.005","article-title":"The management of osteomyelitis in the adult","volume":"14","author":"Maffulli","year":"2016","journal-title":"Surgeon"},{"key":"10.1016\/j.artd.2024.101505_bib5","article-title":"Diagnosis and treatment modalities for osteomyelitis","volume":"14","author":"Jha","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.artd.2024.101505_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14245\/kjs.2014.11.3.113","article-title":"Adverse drug reactions of long-term intravenous antibiotics in patients with pyogenic spondylitis","volume":"11","author":"Kim","year":"2014","journal-title":"Korean J Spine"},{"key":"10.1016\/j.artd.2024.101505_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5194\/jbji-7-191-2022","article-title":"Intravenous antibiotic duration in the treatment of prosthetic joint infection: systematic review and meta-analysis","volume":"7","author":"Bouji","year":"2022","journal-title":"J\u00a0Bone Jt Infect"},{"key":"10.1016\/j.artd.2024.101505_bib8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/antibiotics12060944","article-title":"Systemic antimicrobial treatment of chronic osteomyelitis in adults: a narrative review","volume":"12","author":"Besal","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.artd.2024.101505_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1086\/380964","article-title":"Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital","volume":"38","author":"R\u00fcttimann","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.artd.2024.101505_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0149-2918(07)80085-3","volume":"29","author":"McCollum","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.artd.2024.101505_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40262-021-01088-w","article-title":"Clinical pharmacokinetics and pharmacodynamics of dalbavancin","volume":"61","author":"Molina","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.artd.2024.101505_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/antibiotics10091129","article-title":"Use of dalbavancin in skin, bone and joint infections: a real-life experience in an Italian center","volume":"10","author":"Brescini","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.artd.2024.101505_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/jac\/dkv357","article-title":"Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis","volume":"71","author":"Barnea","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.artd.2024.101505_bib16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/antibiotics10060656","article-title":"Dalbavancin for the treatment of prosthetic joint infections: a narrative review","volume":"10","author":"Buz\u00f3n-Mart\u00edn","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.artd.2024.101505_bib17","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood disadvantage metrics accessible: the neighborhood atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.artd.2024.101505_bib18","article-title":"Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety","volume":"6","author":"Rappo","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.artd.2024.101505_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cid\/civ982","article-title":"A\u00a0randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection","volume":"62","author":"Dunne","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.artd.2024.101505_bib20","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkz162","article-title":"On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections","volume":"74","author":"Morrisette","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.artd.2024.101505_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jhm.2582","article-title":"Perceptions and practices of physicians regarding outpatient parenteral antibiotic therapy in persons who inject drugs","volume":"11","author":"Fanucchi","year":"2016","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.artd.2024.101505_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijantimicag.2017.12.011","article-title":"Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016)","volume":"51","author":"Pfaller","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.artd.2024.101505_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ame2.12149","article-title":"Innovations in osteomyelitis research: a review of animal models","volume":"4","author":"Roux","year":"2021","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.artd.2024.101505_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12866-014-0207-5","article-title":"Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection","volume":"14","author":"Hamza","year":"2014","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.artd.2024.101505_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02280-18","article-title":"Safety and efficacy of prolonged Use of dalbavancin in bone and joint infections","volume":"63","author":"Morata","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.artd.2024.101505_bib26","first-page":"1222","article-title":"The current and future off-label uses of dalbavancin: a narrative review","volume":"27","author":"De Vito","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.artd.2024.101505_bib27","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2022.229","article-title":"Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy","volume":"2","author":"Tuan","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.artd.2024.101505_bib28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s15010-019-01354-x","article-title":"Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infection","volume":"47","author":"Tobudic","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.artd.2024.101505_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/microorganisms11030550","article-title":"Corynebacterium striatum prosthetic joint infection successfully treated with long-term dalbavancin","volume":"11","author":"S\u00f6derquist","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.artd.2024.101505_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijid.2019.02.013","article-title":"Multicenter clinical experience of real life Dalbavancin use in gram-positive infections","volume":"81","author":"Wunsch","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.artd.2024.101505_bib31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1469-0691.1997.tb00280.x","article-title":"Efficacy and safety of vancomycin constant-rate infusion in the treatment of chronic gram-positive bone and joint infections","volume":"3","author":"Bernard","year":"1997","journal-title":"Clin Microbiol Infect"}],"container-title":["Arthroplasty Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344124001900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344124001900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T21:08:25Z","timestamp":1738012105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352344124001900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"alternative-id":["S2352344124001900"],"URL":"https:\/\/doi.org\/10.1016\/j.artd.2024.101505","relation":{},"ISSN":["2352-3441"],"issn-type":[{"value":"2352-3441","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dalbavancin Use in Bone and Joint Infections","name":"articletitle","label":"Article Title"},{"value":"Arthroplasty Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.artd.2024.101505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101505"}}